Literature DB >> 15019158

Brusatol-induced HL-60 cell differentiation involves NF-kappaB activation.

Muriel Cuendet1, Joell J Gills, John M Pezzuto.   

Abstract

Brusatol, a quassinoid isolated from the fruit of Brucea javanica, induces cell differentiation with various leukemic cell lines in the concentration range of 5-25 ng/ml. To investigate its mechanism of action, cultured HL-60 cells were treated with brusatol (25 ng/ml) for various periods of time and qualitatively analyzed for differential gene expression using a cDNA macroarray. As suggested by these preliminary data, we investigated the effect of brusatol on the Rel/nuclear factor-kappa B (NF-kappaB) family members and their role in HL-60 cell differentiation. When cells were treated with brusatol (25 ng/ml), p100/p52, p105/p50 and p65 mRNA were found to be up-regulated with a maximum after 8 h. As determined by electrophoretic mobility shift assays (EMSA), NF-kappaB was activated, involving p50 and p65. Moreover, immunoblots showed a decrease of IkappaBalpha and generation of the phosphorylated form of IkappaBalpha in whole cell lysates. Cell differentiation induced by brusatol was inhibited by SN50, a NF-kappaB translocation inhibitor. These results strongly suggest that brusatol induces activation of NF-kappaB and the activation and translocation of NF-kappaB into the nucleus is responsible for promoting HL-60 cell differentiation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15019158     DOI: 10.1016/j.canlet.2003.11.011

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  15 in total

1.  Bruceantin inhibits multiple myeloma cancer stem cell proliferation.

Authors:  Mark E Issa; Sarah Berndt; Gilles Carpentier; John M Pezzuto; Muriel Cuendet
Journal:  Cancer Biol Ther       Date:  2016-07-19       Impact factor: 4.742

2.  Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism.

Authors:  Dongmei Ren; Nicole F Villeneuve; Tao Jiang; Tongde Wu; Alexandria Lau; Henry A Toppin; Donna D Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-04       Impact factor: 11.205

3.  Glaucarubinone inhibits colorectal cancer growth by suppression of hypoxia-inducible factor 1α and β-catenin via a p-21 activated kinase 1-dependent pathway.

Authors:  Nhi Huynh; John A Beutler; Arthur Shulkes; Graham S Baldwin; Hong He
Journal:  Biochim Biophys Acta       Date:  2014-10-22

4.  Antimalarial activity of simalikalactone E, a new quassinoid from Quassia amara L. (Simaroubaceae).

Authors:  N Cachet; F Hoakwie; S Bertani; G Bourdy; E Deharo; D Stien; E Houel; H Gornitzka; J Fillaux; S Chevalley; A Valentin; V Jullian
Journal:  Antimicrob Agents Chemother       Date:  2009-08-10       Impact factor: 5.191

5.  Induction of murine embryonic stem cell differentiation by medicinal plant extracts.

Authors:  Kurt A Reynertson; Mary E Charlson; Lorraine J Gudas
Journal:  Exp Cell Res       Date:  2010-10-15       Impact factor: 3.905

Review 6.  Research of Brucea javanica against cancer.

Authors:  Zheng Yan; Gui-Fang Guo; Bei Zhang
Journal:  Chin J Integr Med       Date:  2016-04-04       Impact factor: 1.978

7.  Evaluation of antidiabetic and antioxidant properties of Brucea javanica seed.

Authors:  Abdulwali Ablat; Jamaludin Mohamad; Khalijah Awang; Jamil A Shilpi; Aditya Arya
Journal:  ScientificWorldJournal       Date:  2014-02-05

8.  Involvement of autophagy inhibition in Brucea javanica oil emulsion-induced colon cancer cell death.

Authors:  Zheng Yan; Bei Zhang; Yuanyuan Huang; Huijuan Qiu; Ping Chen; Gui-Fang Guo
Journal:  Oncol Lett       Date:  2015-01-14       Impact factor: 2.967

9.  Network understanding of herb medicine via rapid identification of ingredient-target interactions.

Authors:  Hai-Ping Zhang; Jian-Bo Pan; Chi Zhang; Nan Ji; Hao Wang; Zhi-Liang Ji
Journal:  Sci Rep       Date:  2014-01-16       Impact factor: 4.379

Review 10.  Cytoprotection "gone astray": Nrf2 and its role in cancer.

Authors:  Claudia Geismann; Alexander Arlt; Susanne Sebens; Heiner Schäfer
Journal:  Onco Targets Ther       Date:  2014-08-26       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.